125 related articles for article (PubMed ID: 17085056)
1. Anal carcinoma of the elderly treated with radiotherapy alone or with concomitant radio-chemotherapy.
Fallai C; Cerrotta A; Valvo F; Badii D; Olmi P
Crit Rev Oncol Hematol; 2007 Mar; 61(3):261-8. PubMed ID: 17085056
[TBL] [Abstract][Full Text] [Related]
2. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
[TBL] [Abstract][Full Text] [Related]
3. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.
Ferrigno R; Nakamura RA; Dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV; Filho WJ; Lopes A
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1136-42. PubMed ID: 15752894
[TBL] [Abstract][Full Text] [Related]
4. Squamous cell carcinoma of the anal margin.
Newlin HE; Zlotecki RA; Morris CG; Hochwald SN; Riggs CE; Mendenhall WM
J Surg Oncol; 2004 May; 86(2):55-62; discussion 63. PubMed ID: 15112245
[TBL] [Abstract][Full Text] [Related]
5. Size does matter: can we reduce the radiotherapy field size for selected cases of anal canal cancer undergoing chemoradiation?
Crowley C; Winship AZ; Hawkins MA; Morris SL; Leslie MD
Clin Oncol (R Coll Radiol); 2009 Jun; 21(5):376-9. PubMed ID: 19282157
[TBL] [Abstract][Full Text] [Related]
6. Elective inguinal node irradiation in early-stage T2N0 anal cancer: prognostic impact on locoregional control.
Zilli T; Betz M; Bieri S; Ris F; Roche B; Roth AD; Allal AS
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):60-6. PubMed ID: 23608237
[TBL] [Abstract][Full Text] [Related]
7. Patterns of failure and outcome in patients with carcinoma of the anal margin.
Khanfir K; Ozsahin M; Bieri S; Cavuto C; Mirimanoff RO; Zouhair A
Ann Surg Oncol; 2008 Apr; 15(4):1092-8. PubMed ID: 18231838
[TBL] [Abstract][Full Text] [Related]
8. [Long-term results and prognostic factors of squamous cell carcinoma of the anal canal treated by irradiation].
Tournier-Rangeard L; Peiffert D; Lafond C; Mege A; Metayer Y; Marchesi V; Buchheit I; Uwer L; Conroy T; Kaminsky MC
Cancer Radiother; 2007 Jun; 11(4):169-77. PubMed ID: 17400501
[TBL] [Abstract][Full Text] [Related]
9. [Prognosis of epidermoid anal carcinoma regression after conservative treatment].
Vorob'ëv GI; Odariuk TS; Orlova LP; Nechushkin MI; Rybakov EG
Vopr Onkol; 2004; 50(6):663-7. PubMed ID: 15755059
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy for epidermoid carcinoma of the anus: thirty years' experience.
Myerson RJ; Outlaw ED; Chang A; Birnbaum EH; Fleshman JW; Grigsby PW; Kodner IJ; Malayapa RS; Mutch MG; Parikh P; Picus J; Tan BR
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):428-35. PubMed ID: 19251377
[TBL] [Abstract][Full Text] [Related]
11. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma.
Oehler-Jänne C; Seifert B; Lütolf UM; Studer G; Glanzmann C; Ciernik IF
Brachytherapy; 2007; 6(3):218-26. PubMed ID: 17681244
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.
Seo Y; Kinsella MT; Reynolds HL; Chipman G; Remick SC; Kinsella TJ
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):143-9. PubMed ID: 19203845
[TBL] [Abstract][Full Text] [Related]
14. Results of concomitant chemoradiation for cervical cancer using high dose rate intracavitary brachytherapy: study of JROSG (Japan Radiation Oncology Study Group).
Sakata K; Sakurai H; Suzuki Y; Katoh S; Ohno T; Toita T; Kataoka M; Tanaka E; Kaneyasu Y; Uno T; Harima Y; Nakano T;
Acta Oncol; 2008; 47(3):434-41. PubMed ID: 18348003
[TBL] [Abstract][Full Text] [Related]
15. Treatment of squamous cell anal canal carcinoma (SCACC) with pulsed dose rate brachytherapy: a retrospective study.
Bruna A; Gastelblum P; Thomas L; Chapet O; Bollet MA; Ardiet JM; Gérard JP; Peiffert D
Radiother Oncol; 2006 Apr; 79(1):75-9. PubMed ID: 16631268
[TBL] [Abstract][Full Text] [Related]
16. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
[TBL] [Abstract][Full Text] [Related]
17. Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma.
Nuyts S; Dirix P; Clement PM; Poorten VV; Delaere P; Schoenaers J; Hermans R; Van den Bogaert W
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1088-95. PubMed ID: 18707823
[TBL] [Abstract][Full Text] [Related]
18. Radiation dose associated with local control in advanced anal cancer: retrospective analysis of 129 patients.
Widder J; Kastenberger R; Fercher E; Schmid R; Langendijk JA; Dobrowsky W; Pötter R
Radiother Oncol; 2008 Jun; 87(3):367-75. PubMed ID: 18501453
[TBL] [Abstract][Full Text] [Related]
19. Involved-field, low-dose chemoradiotherapy for early-stage anal carcinoma.
Hatfield P; Cooper R; Sebag-Montefiore D
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):419-24. PubMed ID: 17919842
[TBL] [Abstract][Full Text] [Related]
20. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.
Salama JK; Mell LK; Schomas DA; Miller RC; Devisetty K; Jani AB; Mundt AJ; Roeske JC; Liauw SL; Chmura SJ
J Clin Oncol; 2007 Oct; 25(29):4581-6. PubMed ID: 17925552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
